Skip to content
Open access

Comparative Network Pharmacology and Molecular Docking Analysis of Ursodeoxycholic Acid and Tauroursodeoxycholic Acid in Alzheimer’s Disease-Associated Molecular Networks

Sep 2026 · Pharmaceuticals · Vol 19 · 0 citations · 40 references
Medicine

TL;DR

Results from approaches examining systems and structure both indicate that ursodeoxycholic acid and tauroursodeoxycholic acid show profiles of action that work together, but they should not be interpreted as direct evidence of therapeutic efficacy in Alzheimer’s disease.

Abstract

Background/Objectives: Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by amyloid- and tau-related pathology, neuroinflammation, metabolic dysregulation, and neuronal loss. Previous studies have shown the potential effects of bile acids, especially ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), on neurodegenerative diseases. However, whether UDCA and TUDCA exhibit distinct molecular interaction patterns within an Alzheimer’s disease-associated biological context remains unclear. This study aims to compare the relevant targets, enrichment pathways, and docking profiles predicted by UDCA and TUDCA using the computer network pharmacology framework. Methods: The study combined analysis of networks relating to drug action with methods examining how structures bind. We predicted potential targets of UDCA and TUDCA by using public databases and intersected with AD-related genes. Protein–protein interaction network construction, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses, and integrated compound–target–pathway network analysis were performed. Key targets were further evaluated by molecular docking to characterize predicted binding patterns and ligand–target interaction profiles. Results: UDCA and TUDCA share 98 and 103 intersecting genes with AD, respectively, with significant overlapping targets. Functional enrichment analysis showed that UDCA-related targets were significantly enriched in nuclear receptor activity, transcriptional regulation, and metabolic pathways. TUDCA-related targets are more significantly enriched in cell survival, kinase activity and neural activity ligand–receptor interactions. Molecular docking analyses provided target-specific structural information, while same-target docking using GPBAR1 and MAPK14 further revealed ligand-dependent differences in predicted interaction patterns under identical receptor conditions. Results from approaches examining systems and structure both indicate that ursodeoxycholic acid and tauroursodeoxycholic acid show profiles of action that work together. UDCA was associated with predicted upstream regulatory and metabolic-related target profiles, whereas TUDCA showed greater association with intracellular signaling, apoptosis-related, and neuronal survival-related pathways. Conclusions: The two bile acids showed predicted associations with pathways related to cell death regulation, inflammation, and metabolism. These findings provide a methodological basis and testable hypotheses for future experimental validation, but they should not be interpreted as direct evidence of therapeutic efficacy in Alzheimer’s disease.

Read PDF

Similar papers

Sep 2026

Deciphering the Molecular Mechanisms of Apigenin in Neurodegenerative Diseases Through Network Pharmacology, Molecular Docking, and DFT Analysis

Its favorable binding characteristics, electronic stability, and predicted brain permeability highlight apigenin as a potential candidate for the prevention and treatment of neurodegenerative diseases, warranting further experimental and clinical validation.

Anish Singh, Diksha Dalal, Lovedeep Singh · 0 citations
Open access Sep 2026

Multi-target modulation of the neuroinflammatory network by asiatic acid in ischemic stroke: Integrated network pharmacology, molecular docking, and in vitro validation 

Findings support a hypothesis in which AA modulates an interconnected neuroinflammatory and stress-response network rather than a single molecular target, expanding the therapeutic rationale for AA in ischemic stroke while defining specific targets and pathways for future mechanistic investigation.

Jun-jun Gong, Kok-Hong Tang · 0 citations
Open access 2026

Neuroprotective role of hydroxychloroquine and trimebutine in alzheimer’s disease: Network pharmacology and molecular simulations

An integrated in silico approach consisting of network pharmacology, molecular docking, molecular dynamics simulation, gene expression profiling using AlzData and cell permeability analysis was used to evaluate the therapeutic efficacy of Trimebutine and Hydroxychloroquine against Alzheimer's disease, establishing stab...

Renukaradhya Maharudraiah, K. Kant, Madhusudhan Reddy Alimeneti et al. · 0 citations
Sep 2026

Network Pharmacology and Experimental Validation of the Ameliorative Effect of Rosa rugosa Essential Oil on Scopolamine‐Induced Cognitive Dysfunction in Mice

Animal experiments demonstrated that RrEO improved cognitive behaviour in mice, reduced central cholinergic neuronal damage and oxidative stress in the brain, increased the levels of monoamine neurotransmitters dopamine and 5‐hydroxytryptamine (5‐HT), preserved neuronal cell structure, and decreased cell apoptosis.

Wei Wang, Xin Fang, Liu-Jing Huang et al. · 0 citations
Aug 2026

In Silico Multitarget Profiling of Betulinic Acid: ADME/Protox-II Toxicity, Network Pharmacology, and Molecular Docking for Diabetic Osteoporosis.

BA is a secure multi-target treatment option for DO, providing molecular insights for forthcoming experimental validation and multi-target interactions of BA, especially with key signaling pathways, indicate a broad involvement in the metabolic and inflammatory processes contributing to the development of DO.

Sheenam Sharma, Rishabh Chaudhary, Chirag Sharma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.